RollingStone Co., Ltd. (KOSDAQ:214610)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,290.00
-55.00 (-2.35%)
At close: Mar 23, 2026
-58.74%
Market Cap 19.18B
Revenue (ttm) 891.68M
Net Income (ttm) -21.07B
Shares Out 8.38M
EPS (ttm) -345.66
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 32,326
Average Volume 25,457
Open 2,330.00
Previous Close 2,345.00
Day's Range 2,290.00 - 2,575.00
52-Week Range 2,255.00 - 8,470.00
Beta 0.26
RSI 29.92
Earnings Date Mar 27, 2026

About RollingStone

RollingStone Co., Ltd. provides point-of-care-testing diagnostic systems based on Lab-on-a-Chip technology. The company offers molecular diagnostics devices comprising Veri-Q PREP M16 (G2-16TU) system, a device that include membrane to extract nucleic acid using tube; VERI-Q PCR 316, a device to get the result in a short time using plastic chip; VERI-Q PCR 204 (G2-4), a device to deliver the real-time PCR system; PCR and sample prep kits; Veri-Q PCR 316 PB products; and LabChip, sample tube, and pre-filtering column products. It also provides b... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2009
Employees 48
Stock Exchange KOSDAQ
Ticker Symbol 214610
Full Company Profile

Financial Performance

In 2024, RollingStone's revenue was 4.64 billion, a decrease of -13.55% compared to the previous year's 5.37 billion. Losses were -30.85 billion, 19.7% more than in 2023.

Financial Statements

News

There is no news available yet.